Clinical Trials Browser

Interventional × Hematologic Neoplasms × Thymalfasin × Clear all

NCT06584006 2024-09-19

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

Phase 2 Recruiting

Other hematologic neoplasm

Lymphopenia, Hematologic Neoplasms

NCT00580450 2007-12-24

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

Phase 1/2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms